A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Recruiting

Phase 1

RGLS8429A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Sponsor:

Regulus Therapeutics Inc.

Code:

NCT05521191

Conditions

Autosomal Dominant Polycystic Kidney Disease

ADPKD

Polycystic Kidney, Autosomal Dominant

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

RGLS8429

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-29. This information was provided to ClinicalTrials.gov by Regulus Therapeutics Inc. on 2024-04-30.